Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial

Background. Diuresis is a major therapy for the reduction of congestive symptoms in acute decompensated heart failure (ADHF) patients. We previously reported the efficacy and safety of tolvaptan compared to carperitide in hospitalized patients with ADHF. There were some reports of cardio- and renal-...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Satoshi, Yoshihisa, Akiomi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Nakazato, Kazuhiko, Abe, Yukihiko, Saito, Tomiyoshi, Ohwada, Takayuki, Suzuki, Hitoshi, Saitoh, Shu-ichi, Kubota, Isao, Takeishi, Yasuchika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243738/
https://www.ncbi.nlm.nih.gov/pubmed/25436213
http://dx.doi.org/10.1155/2014/704289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243738/
https://www.ncbi.nlm.nih.gov/pubmed/25436213
http://dx.doi.org/10.1155/2014/704289

Ejemplares similares